BEAM EBITDA Margin
Beam Therapeutics Inc · EBITDA Margin
BEAM EBITDA Margin
Latest reported-40.49%period ending
BEAM TTM EBITDA Margin (-913666.65% → -40.49%)
TTM ebitda margin
High-resolution chart · PNG
BEAM ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -40.4935% | |
| -26.0159% | |
| -41.2887% | |
| -704.7881% | |
| -624.8324% | |
| -574.5415% | |
| -558.5472% | |
| -34.4185% | |
| -34.0503% | |
| -31.1916% | |
| -29.4272% | |
| -360.5942% | |
| -382.8219% | |
| -387.8194% | |
| -445.7173% | |
| -156.6285% | |
| -86.7167% | |
| -120.6222% | |
| -396.9061% | |
| -43,457.3624% | |
| -1,454,737.5% | |
| -1,248,937.5% | |
| -533,437.5% | |
| -474,445.8333% | |
| -395,333.3333% | |
| -360,554.1667% | |
| -398,061.1111% | |
| -524,266.6583% | |
| -913,666.65% |